Issue link: https://viewer.e-digitaledition.com/i/1429589
head and neck tumors. For patients with prostate cancer, PET/MRI helps detect recurrent tumors for patients with increased PSA post-treatment. "The FDA approved Gallium 68 PSMA-11, which is an important tool that helps us assess prostate cancer," Dr. Khoury says. "We can detect cancer and see whether or not it has spread, with less radiation exposure. For prostate cancer, PET/MRI is the best test we have to this point." Neurological Disorders PET/MRI can be used to differentiate Alzheimer's disease from other neurological disorders, which is more important than ever with the introduction of the first FDA-approved therapy to potentially treat the underlying causes of Alzheimer's disease. One study showed PET/ MRI had a 94% accuracy rate when used to differentiate Alzheimer's disease from frontotemporal lobar degen- eration. PET/MRI also is being expanded and applied in cases of epilepsy, stroke, traumatic brain injury and movement disorders. For certain seizures, PET/MRI is a better choice than MRI or CT alone to detect abnormal areas and guide surgical treatment. "Besides A lzheimer's, we have the technolog y and ability now to enter into other research programs," Dr. Khoury says. n To learn more about the PET/MRI and diagnostic imaging at White Plains Hospital, visit wphospital.org/petmri. The Future of PET/MRI CURRENT RE SE A RCH INDICATE S promising avenues for translating the advantages of PET/MRI and its expanding capabilities into improved diagnostic and therapeutic applications. Here are exciting advances to look out for in the future: Breast cancer imaging: Current evidence does not support the use of PET in breast cancer imaging. However, advances in PET radiomics may widen the spectrum of features, especially when combined with MRI. PET may be a trend to watch for in the clinical management of breast cancer. Cardiac applications: PET/MRI is a promising approach to detect and characterize ischemic and non- ischemic cardiomyopathies. Improvements to Alzheimer's disease detection: In the future, the use of PET/MRI may further improve the diagnosis of Alzheimer's disease with the use of amyloid- and tau tangle- specific tracers. Infectious and inflammatory diseases: Until recently, SPECT and planar imaging were primary techniques to acquire imaging of infection or inflammation. The addition of more PET radiopharmaceuticals allows for more nuanced detection and quantification of certain aspects of inflammatory processes. This means that the application of hybrid whole-body PET/MRI can help investigate infectious and inflammatory diseases, including Crohn's disease and ulcerative colitis. " Treatment is evolving, which means we have to stay up-to-date with the latest in diagnostic technology. This new PET/MRI scanner allows us to provide exceptional care for everyone from children with cancer to adults with prostate cancer, without the potentially harmful impact of excess radiation. We are proud to offer this technology close to home for your patients' convenience." — ANDRE KHOURY, MD, CO-DIRECTOR OF RADIOLOGY AT WHITE PLAINS HOSPITAL M D N E W S . C O M /// M D N E W S L O W E R H U D S O N / B R O N x ■ 2 0 21 1 3

